Hemin controls T cell polarization in sickle cell alloimmunization

Journal of Immunology

Volumn 193, Issue 1, 2014, Pages 102-110

  Zhong, Hui ^a   Bao, Weili ^a   Friedman, David ^b   Yazdanbakhsh, Karina ^a  

^a NEW YORK BLOOD CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; CD16 ANTIGEN; GAMMA INTERFERON; HEME OXYGENASE 1; HEMIN; INTERLEUKIN 12; PROTOPORPHYRIN ZINC;

ADOLESCENT; ADULT; ALLOIMMUNIZATION; ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL POLARITY; CELL STIMULATION; CONTROLLED STUDY; ENZYME REGULATION; ERYTHROCYTE; HUMAN; HUMAN CELL; IMMUNOREGULATION; INNATE IMMUNITY; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SICKLE CELL ANEMIA; TH1 CELL;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ERYTHROCYTES; FEMALE; GPI-LINKED PROTEINS; HEME OXYGENASE-1; HEMIN; HUMANS; INTERLEUKIN-12; ISOANTIBODIES; MALE; MONOCYTES; RECEPTORS, IGG; T-LYMPHOCYTES, REGULATORY; TH1 CELLS;

EID: 84903637752     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400105     Document Type: Article

References (55)

1. Frenette, P. S., and G. F. Atweh. 2007. Sickle cell disease: old discoveries, new concepts, and future promise. J. Clin. Invest. 117: 850-858. (Pubitemid 46556737)
2. Josephson, C. D., L. L. Su, K. L. Hillyer, and C. D. Hillyer. 2007. Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines. Transfus. Med. Rev. 21: 118-133. (Pubitemid 46482993)
3. Yazdanbakhsh, K., R. E. Ware, and F. Noizat-Pirenne. 2012. Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 120: 528-537.
4. Chou, S. T., T. Jackson, S. Vege, K. Smith-Whitley, D. F. Friedman, and C. M. Westhoff. 2013. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 122: 1062-1071.
5. Bao, W., H. Zhong, X. Li, M. T. Lee, J. Schwartz, S. Sheth, and K. Yazdanbakhsh. 2011. Immune regulation in chronically transfused alloantibody responder and nonresponder patients with sickle cell disease and b-thalassemia major. Am. J. Hematol. 86: 1001-1006.
6. Bao, W., H. Zhong, D. Manwani, L. Vasovic, J. Uehlinger, M. T. Lee, S. Sheth, P. Shi, and K. Yazdanbakhsh. 2013. Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell disease. Am. J. Hematol. 88: 736-740.
7. Platt, O. S. 2000. Sickle cell anemia as an inflammatory disease. J. Clin. Invest. 106: 337-338. (Pubitemid 30655633)
8. Dumont, L. J., and J. P. AuBuchon. 2008. Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials. Transfusion 48: 1053-1060. (Pubitemid 351793478)
9. Ryter, S. W., J. Alam, and A. M. Choi. 2006. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 86: 583-650.
10. Willis, D., A. R. Moore, R. Frederick, and D. A. Willoughby. 1996. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat. Med. 2: 87-90. (Pubitemid 26029572)
11. Piazza, M., G. Damore, B. Costa, T. L. Gioannini, J. P. Weiss, and F. Peri. 2011. Hemin and a metabolic derivative coprohemin modulate the TLR4 pathway differently through different molecular targets. Innate Immun. 17: 293-301.
12. Takeda, Y., M. Takeno, M. Iwasaki, H. Kobayashi, Y. Kirino, A. Ueda, K. Nagahama, I. Aoki, and Y. Ishigatsubo. 2004. Chemical induction of HO-1 suppresses lupus nephritis by reducing local iNOS expression and synthesis of anti-dsDNA antibody. Clin. Exp. Immunol. 138: 237-244. (Pubitemid 39472439)
13. Ma, J. L., P. Y. Yang, Y. C. Rui, L. Lu, H. Kang, and J. Zhang. 2007. Hemin modulates cytokine expressions in macrophage-derived foam cells via heme oxygenase-1 induction. J. Pharmacol. Sci. 103: 261-266. (Pubitemid 46465768)
14. Kapturczak, M. H., C. Wasserfall, T. Brusko, M. Campbell-Thompson, T. M. Ellis, M. A. Atkinson, and A. Agarwal. 2004. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1- deficient mouse. Am. J. Pathol. 165: 1045-1053. (Pubitemid 39129309)
15. Serbina, N. V., T. Jia, T. M. Hohl, and E. G. Pamer. 2008. Monocyte-mediated defense against microbial pathogens. Annu. Rev. Immunol. 26: 421-452. (Pubitemid 351600381)
16. Evans, H. G., N. J. Gullick, S. Kelly, C. Pitzalis, G. M. Lord, B.W. Kirkham, and L. S. Taams. 2009. In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses. Proc. Natl. Acad. Sci. USA 106: 6232-6237.
17. Movahedi, K., M. Guilliams, J. Van den Bossche, R. Van den Bergh, C. Gysemans, A. Beschin, P. De Baetselier, and J. A. Van Ginderachter. 2008. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111: 4233-4244.
18. Zhong, H., W. Bao, X. Li, A. Miller, C. Seery, N. Haq, J. Bussel, and K. Yazdanbakhsh. 2012. CD16+ monocytes control T-cell subset development in immune thrombocytopenia. Blood 120: 3326-3335.
19. Zhong, H., and K. Yazdanbakhsh. 2013. Differential control of Helios+/- Treg development by monocyte subsets through disparate inflammatory cytokines.Blood 121: 2494-2502.
20. Belcher, J. D., P. H. Marker, J. P. Weber, R. P. Hebbel, and G. M. Vercellotti. 2000. Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood 96: 2451-2459.
21. Mizuno, K., T. Toma, H. Tsukiji, H. Okamoto, H. Yamazaki, K. Ohta, K. Ohta, Y. Kasahara, S. Koizumi, and A. Yachie. 2005. Selective expansion of CD16high CCR2- subpopulation of circulating monocytes with preferential production of haem oxygenase (HO)-1 in response to acute inflammation. Clin. Exp. Immunol. 142: 461-470. (Pubitemid 41719842)
22. Wong, R. J., H. J. Vreman, S. Schulz, F. S. Kalish, N. W. Pierce, and D. K. Stevenson. 2011. In vitro inhibition of heme oxygenase isoenzymes by metalloporphyrins. J. Perinatol. 31(Suppl. 1): S35-S41.
23. Pae, H. O., G. S. Oh, B. M. Choi, S. C. Chae, Y. M. Kim, K. R. Chung, and H. T. Chung. 2004. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J. Immunol. 172: 4744-4751.
24. Song, R., R. S. Mahidhara, Z. Zhou, R. A. Hoffman, D. W. Seol, R. A. Flavell, T. R. Billiar, L. E. Otterbein, and A. M. Choi. 2004. Carbon monoxide inhibits T lymphocyte proliferation via caspase-dependent pathway. J. Immunol. 172: 1220-1226. (Pubitemid 38113785)
25. Thornton, A. M., P. E. Korty, D. Q. Tran, E. A. Wohlfert, P. E. Murray, Y. Belkaid, and E. M. Shevach. 2010. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J. Immunol. 184: 3433-3441.
26. Auffray, C., M. H. Sieweke, and F. Geissmann. 2009. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27: 669-692.
27. Choi, B. M., H. O. Pae, Y. R. Jeong, Y. M. Kim, and H. T. Chung. 2005. Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression. Biochem. Biophys. Res. Commun. 327: 1066-1071.
28. George, J. F., A. Braun, T. M. Brusko, R. Joseph, S. Bolisetty, C. H. Wasserfall, M. A. Atkinson, A. Agarwal, and M. H. Kapturczak. 2008. Suppression by CD4+ CD25+ regulatory T cells is dependent on expression of heme oxygenase-1 in antigen-presenting cells. Am. J. Pathol. 173: 154-160. (Pubitemid 351947963)
29. Nath, K. A., J. P. Grande, J. J. Haggard, A. J. Croatt, Z. S. Katusic, A. Solovey, and R. P. Hebbel. 2001. Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease. Am. J. Pathol. 158: 893-903. (Pubitemid 32221782)
30. Jison, M. L., P. J. Munson, J. J. Barb, A. F. Suffredini, S. Talwar, C. Logun, N. Raghavachari, J. H. Beigel, J. H. Shelhamer, R. L. Danner, and M. T. Gladwin. 2004. Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood 104: 270-280. (Pubitemid 38879868)
31. Lanaro, C., C. F. Franco-Penteado, D. M. Albuqueque, S. T. Saad, N. Conran, and F. F. Costa. 2009. Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy. J. Leukoc. Biol. 85: 235-242.
32. Haines, D. D., I. Lekli, P. Teissier, I. Bak, and A. Tosaki. 2012. Role of haeme oxygenase-1 in resolution of oxidative stress-related pathologies: focus on cardiovascular, lung, neurological and kidney disorders. Acta Physiol. (Oxf.) 204: 487-501.
33. Deshane, J., M. Wright, and A. Agarwal. 2005. Heme oxygenase-1 expression in disease states. Acta Biochim. Pol. 52: 273-284. (Pubitemid 41133762)
34. Fagone, P., F. Patti, K. Mangano, S. Mammana, M. Coco, C. Touil-Boukoffa, T. Chikovani, R. Di Marco, and F. Nicoletti. 2013. Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis. J. Neuroimmunol. 261: 82-86.
35. Wong, K. L., W. H. Yeap, J. J. Tai, S. M. Ong, T. M. Dang, and S. C. Wong. 2012. The three human monocyte subsets: implications for health and disease. Immunol. Res. 53: 41-57.
36. Zawada, A. M., K. S. Rogacev, S. H. Schirmer, M. Sester, M. Böhm, D. Fliser, and G. H. Heine. 2012. Monocyte heterogeneity in human cardiovascular disease. Immunobiology 217: 1273-1284.
37. Byrne, J. C., J. Ní Gabhann, E. Lazzari, R. Mahony, S. Smith, K. Stacey, C. Wynne, and C. A. Jefferies. 2012. Genetics of SLE: functional relevance for monocytes/macrophages in disease. Clin. Dev. Immunol. 2012: 582352.
38. Barbagallo, I., F. Galvano, A. Frigiola, F. Cappello, G. Riccioni, P. Murabito, N. D'Orazio, M. Torella, D. Gazzolo, and G. Li Volti. 2013. Potential therapeutic effects of natural heme oxygenase-1 inducers in cardiovascular diseases. Antioxid. Redox Signal. 18: 507-521.
39. Ryter, S. W., and A. M. Choi. 2010. Heme oxygenase-1/carbon monoxide: novel therapeutic strategies in critical care medicine. Curr. Drug Targets 11: 1485- 1494.
40. Roach, J. P., E. E. Moore, D. A. Partrick, S. S. Damle, C. C. Silliman, R. C. McIntyre, Jr., and A. Banerjee. 2009. Heme oxygenase-1 induction in macrophages by a hemoglobin-based oxygen carrier reduces endotoxinstimulated cytokine secretion. Shock 31: 251-257.
41. Fujimoto, M., M. Nakano, F. Terabe, H. Kawahata, T. Ohkawara, Y. Han, B. Ripley, S. Serada, T. Nishikawa, A. Kimura, et al. 2011. The influence of excessive IL-6 production in vivo on the development and function of Foxp3+ regulatory T cells. J. Immunol. 186: 32-40.
42. Chaudhry, A., R. M. Samstein, P. Treuting, Y. Liang, M. C. Pils, J. M. Heinrich, R. S. Jack, F. T. Wunderlich, J. C. Brüning, W. Müller, and A. Y. Rudensky. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34: 566-578.
43. Schonewille, H., L. M. van de Watering, and A. Brand. 2006. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures? Transfusion 46: 630-635.
44. Rosse, W. F., D. Gallagher, T. R. Kinney, O. Castro, H. Dosik, J. Moohr, W. Wang, and P. S. Levy; The Cooperative Study of Sickle Cell Disease. 1990. Transfusion and alloimmunization in sickle cell disease. Blood 76: 1431- 1437. (Pubitemid 20342762)
45. Chauveau, C., S. Rémy, P. J. Royer, M. Hill, S. Tanguy-Royer, F. X. Hubert, L. Tesson, R. Brion, G. Beriou, M. Gregoire, et al. 2005. Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood 106: 1694-1702. (Pubitemid 41208583)
46. Rémy, S., P. Blancou, L. Tesson, V. Tardif, R. Brion, P. J. Royer, R. Motterlini, R. Foresti, M. Painchaut, S. Pogu, et al. 2009. Carbon monoxide inhibits TLRinduced dendritic cell immunogenicity. J. Immunol. 182: 1877-1884.
47. Bains, S. K., R. Foresti, J. Howard, S. Atwal, C. J. Green, and R. Motterlini. 2010. Human sickle cell blood modulates endothelial heme oxygenase activity: effects on vascular adhesion and reactivity. Arterioscler. Thromb. Vasc. Biol. 30: 305-312.
48. Beckman, J. D., C. Chen, J. Nguyen, V. Thayanithy, S. Subramanian, C. J. Steer, and G. M. Vercellotti. 2011. Regulation of heme oxygenase-1 protein expression by miR-377 in combination with miR-217. J. Biol. Chem. 286: 3194-3202.
49. Bean, C. J., S. L. Boulet, D. Ellingsen, M. E. Pyle, E. A. Barron-Casella, J. F. Casella, A. B. Payne, J. Driggers, H. A. Trau, G. Yang, et al. 2012. Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease. Blood 120: 3822-3828.
50. Garcia-Santos, D., and J. A. Chies. 2010. HO-1 polymorphism as a genetic determinant behind the malaria resistance afforded by haemolytic disorders. Med. Hypotheses 74: 807-813.
51. Nikolic, I., T. Saksida, K. Mangano, M. Vujicic, I. Stojanovic, F. Nicoletti and S. Stosic-Grujicic. 2014. Pharmacological application of carbon monoxide ameliorates islet-directed autoimmunity in mice via anti-inflammatory and antiapoptotic effects. Diabetologia 57: 980-990.
52. Rocuts, F., X. Zhang, J. Yan, Y. Yue, M. Thomas, F. H. Bach, E. Czismadia, and H.Wang. 2010. Bilirubin promotes de novo generation of T regulatory cells. Cell Transplant. 19: 443-451.
53. Lee, S. S., W. Gao, S. Mazzola, M. N. Thomas, E. Csizmadia, L. E. Otterbein, F. H. Bach, and H. Wang. 2007. Heme oxygenase-1, carbon monoxide, and bilirubin induce tolerance in recipients toward islet allografts by modulating T regulatory cells. FASEB J. 21: 3450-3457. (Pubitemid 350075135)
54. Kruger, A. L., S. J. Peterson, M. L. Schwartzman, H. Fusco, J. A. McClung, M. Weiss, S. Shenouda, A. I. Goodman, M. S. Goligorsky, A. Kappas, and N. G. Abraham. 2006. Up-regulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects. J. Pharmacol. Exp. Ther. 319: 1144-1152.
55. Suttner, D. M., and P. A. Dennery. 1999. Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron. FASEB J. 13: 1800-1809. (Pubitemid 29473342)